• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞的密度异质性:血小板活化因子诱导低密度嗜酸性粒细胞的产生。

Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.

作者信息

Yukawa T, Kroegel C, Evans P, Fukuda T, Chung K F, Barnes P J

机构信息

Department of Thoracic Medicine, Brompton Hospital, London, U.K.

出版信息

Immunology. 1989 Sep;68(1):140-3.

PMID:2807369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1385519/
Abstract

We have examined the induction of hypodense eosinophils by platelet-activating factor (PAF), a mediator which may be involved in eosinophil activation in allergic diseases. Guinea-pig eosinophils were incubated with buffer or PAF and applied to continuous Percoll density gradients. Cellular density ranged from 1.0142 to 1.1369 g/ml. Peak eosinophil density in control was 1.0887 +/- 0.0008 g/ml (mean +/- SEM), and 91.1 +/- 1.4% of eosinophils were distributed between 1.0810 and 1.1000 g/ml. Preincubation of eosinophils with PAF(10(-7) M) resulted in a time-dependent and non-cytolytic increase of the number of hypodense eosinophils, with peak densities after incubation for 1 hr and 2 hr of 1.0834 +/- 0.0014 (n = 4, P less than 0.05) and 1.0755 +/- 0.0007 g/ml (n = 6, P less than 0.01), respectively. After incubation for 2 hr, 82.0 +/- 4.9% (n = 6) eosinophils showed a density lower than 1.080 g/ml. Lyso-PAF, the inactive precursor and metabolite of PAF, at a concentration of 10(-7) M had no effect on cell density. The specific PAF receptor antagonist WEB 2086 (10(-6) M) inhibited the PAF-induced density shift by 87.0 +/- 5.3%. Our results demonstrate that a single mediator is able to induce the formation of hypodense eosinophils. We conclude that the appearance of hypodense eosinophils in allergic diseases such as asthma may occur, at least in part, in response to inflammatory mediators which activate these cells.

摘要

我们研究了血小板活化因子(PAF)对低密度嗜酸性粒细胞的诱导作用,PAF是一种可能参与过敏性疾病中嗜酸性粒细胞活化的介质。将豚鼠嗜酸性粒细胞与缓冲液或PAF一起孵育,然后应用于连续的Percoll密度梯度。细胞密度范围为1.0142至1.1369 g/ml。对照组嗜酸性粒细胞的峰值密度为1.0887±0.0008 g/ml(平均值±标准误),91.1±1.4%的嗜酸性粒细胞分布在1.0810至1.1000 g/ml之间。嗜酸性粒细胞与PAF(10⁻⁷ M)预孵育导致低密度嗜酸性粒细胞数量呈时间依赖性且非细胞溶解性增加,孵育1小时和2小时后的峰值密度分别为1.0834±0.0014(n = 4,P<0.05)和1.0755±0.0007 g/ml(n = 6,P<0.01)。孵育2小时后,82.0±4.9%(n = 6)的嗜酸性粒细胞密度低于1.080 g/ml。PAF的无活性前体和代谢产物溶血PAF,浓度为10⁻⁷ M时对细胞密度无影响。特异性PAF受体拮抗剂WEB 2086(10⁻⁶ M)可使PAF诱导的密度变化降低87.0±5.3%。我们的结果表明,单一介质能够诱导低密度嗜酸性粒细胞的形成。我们得出结论,在哮喘等过敏性疾病中出现的低密度嗜酸性粒细胞,至少部分可能是对激活这些细胞的炎症介质的反应。

相似文献

1
Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.嗜酸性粒细胞的密度异质性:血小板活化因子诱导低密度嗜酸性粒细胞的产生。
Immunology. 1989 Sep;68(1):140-3.
2
Stimulation of degranulation from human eosinophils by platelet-activating factor.血小板活化因子对人嗜酸性粒细胞脱颗粒的刺激作用。
J Immunol. 1989 May 15;142(10):3518-26.
3
Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.血小板活化因子刺激豚鼠嗜酸性粒细胞中的环氧化酶活性。血栓素A2和E系列前列腺素的协同生物合成。
J Immunol. 1990 May 1;144(9):3489-97.
4
The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro.活化嗜酸性粒细胞和中性粒细胞对豚鼠气道上皮细胞的体外作用。
Am J Respir Cell Mol Biol. 1990 Apr;2(4):341-53. doi: 10.1165/ajrcmb/2.4.341.
5
Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.血小板活化因子可诱导纯化的人嗜酸性粒细胞释放嗜酸性粒细胞过氧化物酶。
Immunology. 1988 Jul;64(3):559-61.
6
Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation.一种新型噻吩二氮卓衍生物在豚鼠肺中作为血小板活化因子拮抗剂的活性。对血小板活化因子和变应原诱导的嗜酸性粒细胞积聚的影响。
Arzneimittelforschung. 1991 Mar;41(3):224-7.
7
Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.几种生物活性物质诱导的嗜酸性粒细胞趋化作用及阿帕泛在体外对其的影响。
Arzneimittelforschung. 1997 Oct;47(10):1112-6.
8
Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.血小板活化因子在嗜酸性粒细胞跨肺上皮细胞单层迁移中的三重作用:嗜酸性粒细胞趋化剂、启动剂及上皮细胞激活剂。
J Immunol. 1998 Sep 15;161(6):3064-70.
9
Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor.血小板活化因子增强嗜酸性粒细胞IgE受体(FcεR2)的表达及其功能。
J Lipid Mediat. 1990;2 Suppl:S177-86.
10
The effect of the selective PAF antagonist WEB 2170 on PAF and antigen induced airway hyperresponsiveness and eosinophil infiltration.选择性血小板活化因子拮抗剂WEB 2170对血小板活化因子及抗原诱导的气道高反应性和嗜酸性粒细胞浸润的影响。
J Lipid Mediat. 1991 Jul-Aug;4(1):111-21.

引用本文的文献

1
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma.嗜酸性粒细胞炎症:重度哮喘药物治疗的一个有吸引力的靶点。
Biomedicines. 2022 Sep 3;10(9):2181. doi: 10.3390/biomedicines10092181.
2
A simple centrifugation method for harvesting myeloblasts.一种用于收获成髓细胞的简单离心方法。
Int J Hematol. 2001 Oct;74(3):272-6. doi: 10.1007/BF02982060.
3
Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.血小板活化因子诱导的人嗜酸性粒细胞活化。哮喘患者人血嗜酸性粒细胞中环氧化酶代谢产物的生成与释放。
Immunology. 1993 Feb;78(2):279-85.
4
Induction of lung eosinophilia and neutrophilia in guinea pigs following injection of sephadex beads.注射葡聚糖凝胶珠后豚鼠肺部嗜酸性粒细胞增多和中性粒细胞增多。
Inflammation. 1993 Oct;17(5):537-50. doi: 10.1007/BF00914192.
5
The role of eosinophils in asthma.嗜酸性粒细胞在哮喘中的作用。
Lung. 1990;168 Suppl:5-17. doi: 10.1007/BF02718107.
6
Role for platelet-activating factor in asthma.血小板活化因子在哮喘中的作用。
Lipids. 1991 Dec;26(12):1277-9. doi: 10.1007/BF02536547.
7
PAF. A review of its effects, antagonists and possible future clinical implications (Part II).血小板活化因子。其作用、拮抗剂及未来可能的临床意义综述(第二部分)
Drugs. 1991 Aug;42(2):174-204. doi: 10.2165/00003495-199142020-00002.
8
Morphology and density features of eosinophil leukocytes in eosinophilic pneumonia. A case report.嗜酸性粒细胞性肺炎中嗜酸性粒细胞的形态学和密度特征。病例报告。
Clin Investig. 1992 May;70(5):447-53. doi: 10.1007/BF00235531.

本文引用的文献

1
Altered density, metabolism and surface receptors of eosinophils in eosinophilia.嗜酸性粒细胞增多症中嗜酸性粒细胞的密度、代谢及表面受体改变。
Immunology. 1982 Nov;47(3):531-9.
2
Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities.人类嗜酸性粒细胞与寄生虫病。II. 以不同密度分离的两种细胞组分的特性
Clin Exp Immunol. 1982 Apr;48(1):249-55.
3
Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.人类嗜酸性粒细胞的异质性。II. 与细胞密度相关的呼吸爆发活性的变异性。
Clin Exp Immunol. 1984 Sep;57(3):735-42.
4
Increased biosynthesis of platelet-activating factor in activated human eosinophils.活化的人嗜酸性粒细胞中血小板活化因子的生物合成增加。
J Biol Chem. 1984 May 10;259(9):5526-30.
5
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.人类外周血嗜酸性粒细胞的异质性:与嗜酸性粒细胞增多症的程度和来源相关的细胞密度和细胞毒性能力的变异性。
Int Arch Allergy Appl Immunol. 1983;72(4):336-46. doi: 10.1159/000234893.
6
Role of IgE receptors in effector function of human eosinophils.免疫球蛋白E受体在人类嗜酸性粒细胞效应功能中的作用。
J Immunol. 1984 Jan;132(1):462-8.
7
Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma.支气管哮喘患者血液中低密度嗜酸性粒细胞数量增加。
Am Rev Respir Dis. 1985 Nov;132(5):981-5. doi: 10.1164/arrd.1985.132.5.981.
8
Release of leukotriene C4 from human eosinophils and its relation to the cell density.人嗜酸性粒细胞白三烯C4的释放及其与细胞密度的关系。
Int Arch Allergy Appl Immunol. 1985;78(4):406-10. doi: 10.1159/000233922.
9
Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils.血小板活化因子(PAF-乙醚)可诱导人嗜酸性粒细胞生成白三烯C4并产生鲁米诺依赖性化学发光。
Pharmacol Res Commun. 1986 Aug;18 Suppl:61-9. doi: 10.1016/0031-6989(86)90039-1.
10
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.血小板活化因子新型特异性拮抗剂WEB 2086的药理作用
J Pharmacol Exp Ther. 1987 Jun;241(3):974-81.